← FDA Drug Approvals (Drugs@FDA)

ZOKINVY

NDA · New Drug Application · Sponsor: SENTYNL THERAPS INC · Approved 2020-11-20

Drug application

FDA Application #

NDA213969

Application type

New Drug Application

Brand name

ZOKINVY

Generic name

LONAFARNIB

Active ingredients

LONAFARNIB

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

SENTYNL THERAPS INC

Manufacturer

Sentynl Therapeutics, Inc.

First approval

2020-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown